Ingredient guide
Understand semaglutide, Wegovy and other brand relationships, compounded-drug differences, and WellForm local or virtual care and payment steps.
Semaglutide is the active ingredient used in more than one prescription brand.
Wegovy is a specific FDA-approved semaglutide product, not a name for every semaglutide product.
Compounded semaglutide is not FDA-approved and is not generic Wegovy.
The decision in plain language
Brand names are not interchangeable labels. Each product has its own FDA-approved uses, dosage form, prescribing information, access pathway, and pharmacy process.
Semaglutide is the active ingredient; the brand name identifies a specific FDA-approved product.
Wegovy is a semaglutide brand with weight-management indications in its prescribing information.
Other semaglutide brands may have different approved uses and should not be treated as synonyms.
Compounded semaglutide is not FDA-approved and is not a generic Wegovy product.
WellForm discusses the exact product, route, source, and payment path before any prescription decision.
Your care path
WellForm identifies the exact product being considered, evaluates candidacy, explains payment and fulfillment, and monitors care if prescribed.
Choose Ankeny or virtual care and tell us the option you want to discuss.
Review goals, history, current treatment, risks, and practical access.
Clarify the exact service or product, care fee, pharmacy path, and what is not included.
Monitor response, barriers, tolerability when relevant, and the next clinical or practical step.
Ready when you are
An ingredient, not a brand · Wegovy is one labeled product · Compounded is a separate category
What happens next
The consultation, payment explanation, and follow-up plan remain visible before you commit.
Select the page-specific interest when you request an Ankeny or virtual visit.
Dr. Patrick Oben reviews clinical fit and explains the differences that matter.
Agree on the care setting, WellForm fee, and any separate pharmacy transaction.
Clinical fit
The evaluation includes medical history, current treatment, the relevant prescribing information, and practical access considerations.
Ongoing care
A plan can change based on clinical response, side effects, access, and the physician’s judgment.
Benefits and limits
WellForm discusses the exact product, route, source, and payment path before any prescription decision.
Compare your options
Compare the ingredient with the branded weight-management page and with the different tirzepatide ingredient.
Local, virtual, and payment
WellForm medical or support care is one transaction. A prescribed medication is generally a separate transaction with the dispensing pharmacy.
The compounded semaglutide virtual program starts at $195 for the first month, including the current $25 first-month adjustment. The exact product, dose band, ongoing price, and eligibility are confirmed before enrollment.
The in-person compounded semaglutide program starts at $325 per month, including medication; price varies by dose band. Depending on the selected medical weight-loss pathway, clinic support can include InBody scans, UltraSlim red-light support, Ballancer lymphatic care, Power Plate, nutrition guidance, and optional Quest laboratory work when clinically appropriate.
The virtual medical-management fee is $150 per month. Any prescribed brand-name medication is paid separately to the dispensing pharmacy.
The Ankeny support fee is $300 per month. Applicable clinic support depends on the selected program, and any prescribed brand-name medication is paid separately to the dispensing pharmacy.
Before you request care
An ingredient, not a brand
An ingredient, not a brand · Wegovy is one labeled product · Compounded is a separate category
Evidence and authority
FDA materials distinguish approved brand products from unapproved compounded versions and warn about quality, dosing, and fraudulent-product concerns.
Official resources
Still comparing?
WellForm can clarify the page, visit type, and information to bring without promising treatment before evaluation.
FAQ
Clear answers to the questions most likely to affect your decision.
A responsible next step
Request a visit to discuss candidacy, exact product, fulfillment, payment, and follow-up without treating unlike products as equivalent.
